# EDGAR Filing Document

**Accession Number:** 0001751788
**File Stem:** 0001751788-26-000131
**Filing Date:** 2026-4
**Character Count:** 46767
**Document Hash:** e1761f959cbdce742e3f46ee769181ed
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001751788-26-000131.hdr.sgml**: 20260423

**ACCESSION NUMBER**: 0001751788-26-000131

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 14

**CONFORMED PERIOD OF REPORT**: 20260423

**ITEM INFORMATION**: Results of Operations and Financial Condition

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20260423

**DATE AS OF CHANGE**: 20260423

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** DOW INC.
- **CENTRAL INDEX KEY:** 0001751788
- **STANDARD INDUSTRIAL CLASSIFICATION:** PLASTICS, MATERIALS, SYNTH RESINS & NONVULCAN ELASTOMERS [2821]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 301128146
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-38646
- **FILM NUMBER:** 26885474

**BUSINESS ADDRESS:**
- **STREET 1:** 2211 H.H. DOW WAY
- **CITY:** MIDLAND
- **STATE:** MI
- **ZIP:** 48674
- **BUSINESS PHONE:** 9896361000

**MAIL ADDRESS:**
- **STREET 1:** 2211 H.H. DOW WAY
- **CITY:** MIDLAND
- **STATE:** MI
- **ZIP:** 48674

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Dow Inc.
- **DATE OF NAME CHANGE:** 20190305

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Dow Holdings Inc.
- **DATE OF NAME CHANGE:** 20180831

?xml version='1.0' encoding='ASCII'? dow-20260423

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 8-K**

**CURRENT REPORT**

**Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934**

**Date of Report (Date of earliest event reported):**

**April 23, 2026**

![DOWdiamond-red-RGB_8-19.jpg](dow-20260423_g1.jpg)

---

| | | | |
|:---|:---|:---|:---|
| **Commission**<br>**<u>File Number</u>** | **Exact Name of Registrant as Specified in its Charter,**<br>**<u>Principal Office Address and Telephone Number</u>** | **State or other Jurisdiction of** <br>**<u>Incorporation</u>** | **I.R.S. Employer**<br>**<u>Identification No.</u>** |
| 001-38646 | **Dow Inc.** | Delaware | 30-1128146 |
|  | 2211 H.H. Dow Way, Midland, MI 48674 |  |  |
|  | (989) 636-1000 |  |  |

---

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐&nbsp;&nbsp;&nbsp;&nbsp;Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐&nbsp;&nbsp;&nbsp;&nbsp;Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐&nbsp;&nbsp;&nbsp;&nbsp;Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐&nbsp;&nbsp;&nbsp;&nbsp;Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | | |
|:---|:---|:---|:---|
| **Registrant** | **Title of each class** | **Trading Symbol(s)** | **Name of each exchange on which registered** |
| **Dow Inc.** | Common Stock, par value $0.01 per share | DOW | New York Stock Exchange |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

------

**Section 2 - Financial Information**

**Item 2.02 Results of Operations and Financial Condition.**

On April 23, 2026, Dow Inc. issued a press release, attached as Exhibit 99.1 and incorporated herein by reference, announcing results for the first quarter of 2026.

The information contained in this report, including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of Section 18. Furthermore, the information contained in this report shall not be deemed to be incorporated by reference into any registration statement or other document filed pursuant to the Securities Act of 1933, as amended.

**Section 9 - Financial Statements and Exhibits**

**Item 9.01 Financial Statements and Exhibits.**

(d)&nbsp;&nbsp;&nbsp;&nbsp;Exhibits. The exhibit listed on the Exhibit Index is incorporated herein by reference.

---

| | |
|:---|:---|
| Exhibit No. | Exhibit Description |
| 99.1 | <u>[Press release issued by Dow Inc. on](exhibit991enrschedules1q26.htm)[April 23, 202](exhibit991enrschedules1q26.htm)[6](exhibit991enrschedules1q26.htm)[, announcing results for the](exhibit991enrschedules1q26.htm)[first](exhibit991enrschedules1q26.htm)[quarter of](exhibit991enrschedules1q26.htm)[2026](exhibit991enrschedules1q26.htm)[.](exhibit991enrschedules1q26.htm)</u> |
| 104 | Cover Page Interactive Data File. The cover page interactive data file does not appear in the Interactive Data File because its XBRL tags are embedded with the Inline XBRL document. |

---

------

**Signature**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

DOW INC.

Date: April 23, 2026

---

| |
|:---|
| /s/ ANDREA L. DOMINOWSKI |
| Andrea L. Dominowski<br>Controller and Vice President<br>of Controllers |

---

## Exhibit 99.1

![dow-seek_vertxsmbrandlinea.jpg](dow-seek_vertxsmbrandlinea.jpg)

**Exhibit 99.1<br>April 23, 2026**

**Dow reports first quarter 2026 results**

**FINANCIAL HIGHLIGHTS**

• Net sales were $9.8 billion, down 6% year-over-year, reflecting flat sales in Performance Materials & Coatings and declines in the other operating segments.

• Volume decreased 2% year-over-year, driven by declines in Industrial Intermediates & Infrastructure, which was impacted by the Middle East conflict. Gains in Packaging & Specialty Plastics from higher polyethylene volumes were more than offset by lower merchant olefins sales following the idling of a cracker in Europe, the Middle East, Africa and India (EMEAI) in mid-2025 and planned maintenance activity in the U.S. Gulf Coast.

• Local price was down 7% versus the year-ago period.

• The Company suspended Sadara equity loss recognition in the first quarter of 2026 in accordance with GAAP. The carrying value of all liabilities on the balance sheet reached total existing relevant obligations and commitments.

• GAAP net loss was $445 million. Op. EBIT<sup>1</sup> was $154 million, down $76 million year-over-year. This was primarily driven by lower prices, which were partly offset by tailwinds from the Company's cost reduction program.

• GAAP loss per share was $0.74; operating earnings per share (EPS)<sup>1</sup> was a loss of $0.14, compared to earnings of $0.02 in the year-ago period. Op. EPS excludes significant items totaling $0.60 per share, driven by an adjustment to the Sadara guarantee liability and taxes associated with receipt of payment from NOVA Chemicals related to the Company's ongoing litigation.

• Cash provided by operating activities – continuing operations was $1.1 billion, up $1.0 billion year-over-year, primarily driven by receipt of payment from NOVA Chemicals and working capital improvements.

• Returns to shareholders totaled $252 million of dividends in the quarter.

**CEO QUOTE**

"In the first quarter, our results reflect the growing impact of Dow's self-help actions. Additionally, the margin backdrop began to positively inflect in March following global supply constraints, as impacts from the conflict in the Middle East quickly became widespread," said Jim Fitterling, Dow chair and CEO. "The strength of Dow's advantaged portfolio is a clear differentiator, enabling us to win in our key end markets. Our unmatched Americas manufacturing footprint, leading European feedstock flexibility and agile global supply chains allow us to continue to innovate and serve our customers safely and reliably through all cycles and macroeconomic conditions. We also remain steadfast in our commitment to Transform to Outperform, which is already becoming a catalyst for growth, productivity and sustained value creation well into the future."

**SUMMARY FINANCIAL RESULTS**

---

| | | | |
|:---|:---|:---|:---|
| | **Three Months Ended Mar 31** | **Three Months Ended Mar 31** | **Three Months Ended Mar 31** |
| *In millions, except per share amounts* | **<u>1Q26</u>** | **<u>1Q25</u>** | **<u>vs. SQLY [B / (W)]</u>** |
| **Net Sales** | $9794 | $10431 | $(637) |
| **GAAP Income (Loss), Net of Tax** | $(445) | $(290) | $(155) |
| **Operating EBIT**<sup>1</sup> | $154 | $230 | $(76) |
| **Operating EBITDA**<sup>1</sup> | $873 | $944 | $(71) |
| **GAAP Earnings (Loss) Per Share** | $(0.74) | $(0.44) | $(0.30) |
| **Operating Earnings Per Share**<sup>1</sup> | $(0.14) | $0.02 | $(0.16) |
| **Cash Provided by (Used for) Operating Activities - Cont. Ops** | $1124 | $104 | $1020 |

---

1. Op. Earnings Per Share, Op. EBIT, Op. EBIT Margin and Op. EBITDA, Free Cash Flow and Cash Flow Conversion are non-GAAP measures. See page 6 for further discussion.

 <sup>®TM</sup> Trademark of The Dow Chemical Company or an affiliated company of Dow

&nbsp;&nbsp;&nbsp;&nbsp;1

------

Dow reports first quarter 2026 results

**SEGMENT HIGHLIGHTS**

**Packaging & Specialty Plastics**

---

| | | | |
|:---|:---|:---|:---|
| | **Three Months Ended Mar 31** | **Three Months Ended Mar 31** | **Three Months Ended Mar 31** |
| *In millions* | **<u>1Q26</u>** | **<u>1Q25</u>** | **<u>vs. SQLY</u>**<br>**<u>[B / (W)]</u>** |
| **Net Sales** | $4919 | $5310 | $(391) |
| **Operating EBIT** | $208 | $342 | $(134) |

---

Packaging & Specialty Plastics segment net sales in the quarter were $4.9 billion, down 7% versus the year-ago period. Local price decreased 9% year-over-year, primarily driven by lower polyethylene prices. Currency increased net sales by 3%. Volume decreased 1% year-over-year as higher polyethylene volumes in all regions were offset by lower merchant olefins sales and lower licensing revenue.

Op. EBIT was $208 million, a decrease of $134 million compared to the year-ago period, driven by lower integrated margins and higher planned maintenance activity, partly offset by higher polyethylene volumes that were enabled by our new polyethylene unit in Freeport, Texas and tailwinds from the Company's cost reduction program.

<u>Packaging and Specialty Plastics</u> business reported a net sales decrease versus the year-ago period, as lower polyethylene prices and lower licensing revenue were partly offset by higher volume in resilient flexible packaging applications.

<u>Hydrocarbons & Energy</u> business reported a net sales decrease year-over-year, driven by lower merchant olefins sales due to planned maintenance activity in the U.S. Gulf Coast and the idling of a cracker in EMEAI in mid-2025.

**Industrial Intermediates & Infrastructure**

---

| | | | |
|:---|:---|:---|:---|
| | **Three Months Ended Mar 31** | **Three Months Ended Mar 31** | **Three Months Ended Mar 31** |
| *In millions* | **<u>1Q26</u>** | **<u>1Q25</u>** | **<u>vs. SQLY</u>**<br>**<u>[B / (W)]</u>** |
| **Net Sales** | $2626 | $2855 | $(229) |
| **Operating EBIT** | $(118) | $(128) | $10 |

---

Industrial Intermediates & Infrastructure segment net sales were $2.6 billion, down 8% versus the year-ago period. Local price declined 8% year-over-year, reflecting declines in both businesses. Currency increased net sales by 4%. Volume decreased 4% year-over-year, primarily driven by lower volumes in Polyurethanes & Construction Chemicals, including impacts from the Middle East conflict.

Op. EBIT increased $10 million versus the year-ago period, driven by lower planned maintenance activity, the suspension of the recognition of equity losses from Sadara, and tailwinds from the Company's cost reduction program, which were partly offset by lower prices.

<u>Polyurethanes & Construction Chemicals</u> business reported a decrease in net sales compared to the year-ago period, primarily driven by local price, along with lower volumes from the shutdown of our higher-cost upstream propylene oxide unit in the U.S. Gulf Coast in late 2025, and the Middle East conflict.

<u>Industrial Solutions</u> business reported a decrease in net sales compared to the year-ago period, as higher volumes from recent alkoxylation investments and increased demand for data center applications were more than offset by lower local prices and lower licensing revenue.

&nbsp;&nbsp;&nbsp;&nbsp;2

------

Dow reports first quarter 2026 results

**Performance Materials & Coatings**

---

| | | | |
|:---|:---|:---|:---|
| | **Three Months Ended Mar 31** | **Three Months Ended Mar 31** | **Three Months Ended Mar 31** |
| *In millions* | **<u>1Q26</u>** | **<u>1Q25</u>** | **<u>vs. SQLY</u>**<br>**<u>[B / (W)]</u>** |
| **Net Sales** | $2080 | $2071 | $9 |
| **Operating EBIT** | $117 | $49 | $68 |

---

Performance Materials & Coatings segment net sales in the quarter were $2.1 billion, flat versus the year-ago period. Local price decreased 4% year-over-year, driven by a decline in Coatings & Performance Monomers. Currency increased net sales by 2%. Volume increased 2% year-over-year, driven by higher volumes in both businesses, led by growth in downstream silicones and acrylic monomers.

Op. EBIT was $117 million, an increase of $68 million versus the year-ago period. This was driven primarily by volume gains across both businesses and lower fixed costs, including lower planned maintenance activity and tailwinds from the Company's cost reduction program, which were partly offset by lower price.

<u>Consumer Solutions</u> business reported an increase in net sales versus the year-ago period, driven by currency tailwinds and volume gains in downstream silicones, led by gains in electronics applications globally and home and personal care applications in the U.S. & Canada, which were partially offset by lower local prices.

<u>Coatings & Performance Monomers</u> business reported a decrease in net sales compared to the year-ago period, as lower prices were partly offset by higher acrylic monomers volume, primarily in the U.S. & Canada.

**OUTLOOK**

"We are already seeing rapid positive momentum from our announced pricing actions in every business and every region, as well as constructive impacts to our operating rates," said Fitterling. "We are leveraging Dow's purpose-built asset footprint, well-established supply chain routes and leading asset reliability to prioritize our customers and navigate the conflict in the Middle East. At the same time, our teams remain focused on capturing growth in attractive markets while delivering cost savings and cash support. Transform to Outperform aims to radically simplify how we operate, reengineer our processes and cost structures and modernize how we serve our customers. These collective actions position the Company for improved growth and productivity, expanded margins, and higher shareholder returns across the cycle."

**Conference Call**

Dow will host a live webcast of its quarterly earnings conference call with investors to discuss its results, business outlook and other matters today at 8:00 a.m. ET. The webcast and slide presentation that accompany the conference call will be posted on the events and presentations page of investors.dow.com.

**About Dow**

Dow (NYSE: DOW) is one of the world's leading materials science companies, serving customers in high-growth markets such as packaging, infrastructure, mobility and consumer applications. Our global breadth, asset integration and scale, customer-focused innovation and leading business positions enable us to achieve profitable growth and help deliver a sustainable future. We operate manufacturing sites in 29 countries and employ approximately 34,600 people. Dow delivered sales of approximately $40 billion in 2025. References to Dow or the Company mean Dow Inc. and its subsidiaries. Learn more about us at www.dow.com.

###

For further information, please contact:

---

| | |
|:---|:---|
| **Investors:** | **Media:** |
| Andrew Riker | Sarah Young |
| ajriker@dow.com | syoung3@dow.com |

---

&nbsp;&nbsp;&nbsp;&nbsp;3

------

Dow reports first quarter 2026 results

**Cautionary Statement about Forward-Looking Statements** 

Certain statements in this press release are "forward-looking statements" within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements often address expected future business and financial performance, financial condition, and other matters, and often contain words or phrases such as "anticipate," "believe," "could," "estimate," "expect," "intend," "may," "opportunity," "outlook," "plan," "project," "seek," "should," "strategy," "target," "will," "will be," "will continue," "will likely result," "would" and similar expressions, and variations or negatives of these words or phrases.

Forward-looking statements are based on current assumptions and expectations of future events that are subject to risks, uncertainties and other factors that are beyond Dow's control, which may cause actual results to differ materially from those projected, anticipated or implied in the forward-looking statements and speak only as of the date the statements were made. These factors include, but are not limited to: sales of Dow's products; Dow's expenses, future revenues and profitability; any supply chain, operational or other disruptions, sanctions, export restrictions, or increased economic uncertainty related to the ongoing conflicts between Russia and Ukraine and in the Middle East; capital requirements and need for and availability of financing; unexpected barriers in the development of technology, including with respect to Dow's contemplated capital and operating projects; Dow's ability to realize its commitment to carbon neutrality on the contemplated timeframe, including the completion and success of its integrated ethylene cracker and derivatives facility in Alberta, Canada; size of the markets for Dow's products and services and ability to compete in such markets; Dow's ability to develop and market new products and optimally manage product life cycles; the rate and degree of market acceptance of Dow's products; significant litigation and environmental matters and related contingencies and unexpected expenses; the success of competing technologies that are or may become available; the ability to protect Dow's intellectual property in the United States and abroad; Dow's ability to realize expected benefits from Transform to Outperform on the contemplated timeframe; developments related to contemplated restructuring activities and proposed divestitures or acquisitions such as workforce reduction, manufacturing facility and/or asset closure and related exit and disposal activities, and the benefits and costs associated with each of the foregoing; fluctuations in energy and raw material prices; management of process safety and product stewardship; changes in relationships with Dow's significant customers and suppliers; changes in public sentiment and political leadership; increased concerns about plastics in the environment and lack of a circular economy for plastics at scale; changes in consumer preferences and demand; changes in laws and regulations, political conditions, tariffs and trade policies, or industry development; global economic and capital markets conditions, such as inflation, market uncertainty, interest and currency exchange rates, and equity and commodity prices; business, logistics, and supply disruptions; security threats, such as acts of sabotage, terrorism or war, including the ongoing conflicts between Russia and Ukraine and in the Middle East; weather events and natural disasters; disruptions in Dow's information technology networks and systems, including the impact of cyberattacks; risks related to Dow's separation from DowDuPont Inc. such as Dow's obligation to indemnify DuPont de Nemours, Inc. and/or Corteva, Inc. for certain liabilities; and any global and regional economic impacts of a pandemic or other public health-related risks and events on Dow's business.

Where, in any forward-looking statement, an expectation or belief as to future results or events is expressed, such expectation or belief is based on the current plans and expectations of management and expressed in good faith and believed to have a reasonable basis, but there can be no assurance that the expectation or belief will result or be achieved or accomplished. A detailed discussion of principal risks and uncertainties which may cause actual results and events to differ materially from such forward-looking statements is included in the section titled "Risk Factors" contained in the Company's Annual Report on Form 10-K for the year ended December 31, 2025, and the Company's subsequent reports filed with the U.S. Securities and Exchange Commission. These are not the only risks and uncertainties that Dow faces. There may be other risks and uncertainties that Dow is unable to identify at this time or that Dow does not currently expect to have a material impact on its business. If any of those risks or uncertainties develops into an actual event, it could have a material adverse effect on Dow's business. Dow Inc. and The Dow Chemical Company and its consolidated subsidiaries assume no obligation to update or revise publicly any forward-looking statements whether because of new information, future events, or otherwise, except as required by securities and other applicable laws.

<br>®TM Trademark of The Dow Chemical Company or an affiliated company of Dow

&nbsp;&nbsp;&nbsp;&nbsp;4

------

**Non-GAAP Financial Measures**

This earnings release includes information that does not conform to GAAP and are considered non-GAAP measures. Management uses these measures internally for planning, forecasting and evaluating the performance of the Company's segments, including allocating resources. Dow's management believes that these non-GAAP measures best reflect the ongoing performance of the Company during the periods presented and provide more relevant and meaningful information to investors as they provide insight with respect to ongoing operating results of the Company and a more useful comparison of year-over-year results. These non-GAAP measures supplement the Company's GAAP disclosures and should not be viewed as alternatives to GAAP measures of performance. Furthermore, such non-GAAP measures may not be consistent with similar measures provided or used by other companies. Non-GAAP measures included in this release are defined below. Reconciliations for these non-GAAP measures to GAAP are provided in the Selected Financial Information and Non-GAAP Measures section starting on page 11. Dow does not provide forward-looking GAAP financial measures or a reconciliation of forward-looking non-GAAP financial measures to the most comparable GAAP financial measures on a forward-looking basis because the Company is unable to predict with reasonable certainty the ultimate outcome of pending litigation, unusual gains and losses, foreign currency exchange gains or losses and potential future asset impairments, as well as discrete taxable events, without unreasonable effort. These items are uncertain, depend on various factors, and could have a material impact on GAAP results for the guidance period.

Operating Earnings Per Share is defined as "Loss per common share - diluted" excluding the after-tax impact of significant items.

Operating EBIT is defined as earnings (i.e., "Loss before income taxes") before interest, excluding the impact of significant items.

Operating EBIT Margin is defined as Operating EBIT as a percentage of net sales.

Operating EBITDA is defined as earnings (i.e., "Loss before income taxes") before interest, depreciation and amortization, excluding the impact of significant items.

Free Cash Flow is defined as "Cash provided by (used for) operating activities - continuing operations," less capital expenditures. Under this definition, Free Cash Flow represents the cash generated by the Company from operations after investing in its asset base. Free Cash Flow, combined with cash balances and other sources of liquidity, represent the cash available to fund obligations and provide returns to shareholders. Free Cash Flow is an integral financial measure used in the Company's financial planning process.

Cash Flow Conversion is defined as "Cash provided by (used for) operating activities - continuing operations," divided by Operating EBITDA. Management believes Cash Flow Conversion is an important financial metric as it helps the Company determine how efficiently it is converting its earnings into cash flow.

Operating Return on Capital (ROC) is defined as net operating profit after tax, excluding the impact of significant items, divided by total average capital, also referred to as ROIC.

------

**Dow Inc. and Subsidiaries**

**Consolidated Statements of Income**

---

| | | |
|:---|:---|:---|
| In millions, except per share amounts (Unaudited) | *Three Months Ended* | *Three Months Ended* |
| In millions, except per share amounts (Unaudited) | *Mar 31, 2026* | *Mar 31, 2025* |
| Net sales | $9794 | $10431 |
| &nbsp;&nbsp;&nbsp;&nbsp;Cost of sales | 9154 | 9760 |
| &nbsp;&nbsp;&nbsp;&nbsp;Research and development expenses | 181 | 200 |
| &nbsp;&nbsp;&nbsp;&nbsp;Selling, general and administrative expenses | 417 | 366 |
| &nbsp;&nbsp;&nbsp;&nbsp;Amortization of intangibles | 46 | 76 |
| &nbsp;&nbsp;&nbsp;&nbsp;Restructuring and asset related charges - net | 27 | 208 |
| &nbsp;&nbsp;&nbsp;&nbsp;Equity in losses of nonconsolidated affiliates | (303) | (20) |
| &nbsp;&nbsp;&nbsp;&nbsp;Sundry income (expense) - net | 121 | 13 |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest income | 42 | 28 |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest expense and amortization of debt discount | 219 | 216 |
| Loss before income taxes | (390) | (374) |
| &nbsp;&nbsp;&nbsp;&nbsp;Provision (credit) for income taxes | 55 | (84) |
| Net loss | (445) | (290) |
| &nbsp;&nbsp;&nbsp;&nbsp;Net income attributable to noncontrolling interests | 88 | 17 |
| Net loss available for Dow Inc. common stockholders | $(533) | $(307) |
| Per common share data: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Loss per common share - basic | $(0.74) | $(0.44) |
| &nbsp;&nbsp;&nbsp;&nbsp;Loss per common share - diluted | $(0.74) | $(0.44) |
| Weighted-average common shares outstanding - basic | 721.2 | 706.9 |
| Weighted-average common shares outstanding - diluted | 721.2 | 706.9 |

---

------

**Dow Inc. and Subsidiaries**

**Consolidated Balance Sheets**

---

| | | |
|:---|:---|:---|
| In millions, except share amounts (Unaudited) | *Mar 31,<br>2026* | *Dec 31,<br>2025* |
| **Assets** |  |  |
| Current Assets |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash and cash equivalents (variable interest entities restricted - 2026: $259; 2025: $31) | $4110 | $3816 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts and notes receivable: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Trade (net of allowance for doubtful receivables - 2026: $63; 2025: $59) | 5185 | 4762 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other | 2224 | 1876 |
| &nbsp;&nbsp;&nbsp;&nbsp;Inventories | 6775 | 6595 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other current assets | 1175 | 1013 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total current assets (variable interest entities restricted - 2026: $465; 2025: $228) | 19469 | 18062 |
| Investments |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Investment in nonconsolidated affiliates | 1138 | 1264 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other investments (investments carried at fair value - 2026: $2,236; 2025: $2,212) | 3008 | 3017 |
| &nbsp;&nbsp;&nbsp;&nbsp;Noncurrent receivables | 444 | 309 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total investments | 4590 | 4590 |
| Property |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Property | 66017 | 65863 |
| &nbsp;&nbsp;&nbsp;&nbsp;Less: Accumulated depreciation | 43909 | 43613 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net property (variable interest entities restricted - 2026: $2,362; 2025: $2,385) | 22108 | 22250 |
| Other Assets |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Goodwill | 7947 | 7978 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other intangible assets (net of accumulated amortization - 2026: $5,770; 2025: $5,727) | 1426 | 1486 |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating lease right-of-use assets | 1426 | 1356 |
| &nbsp;&nbsp;&nbsp;&nbsp;Deferred income tax assets | 1525 | 1511 |
| &nbsp;&nbsp;&nbsp;&nbsp;Deferred charges and other assets | 1289 | 1305 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total other assets (variable interest entities restricted - 2026: $220; 2025: $226) | 13613 | 13636 |
| Total Assets | $59780 | $58538 |
| **Liabilities and Equity** |  |  |
| Current Liabilities |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Notes payable | $88 | $90 |
| &nbsp;&nbsp;&nbsp;&nbsp;Long-term debt due within one year | 793 | 222 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts payable: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Trade | 4769 | 4151 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other | 1392 | 1394 |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating lease liabilities - current | 348 | 340 |
| &nbsp;&nbsp;&nbsp;&nbsp;Income taxes payable | 344 | 337 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accrued and other current liabilities | 2802 | 2649 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total current liabilities (variable interest entities nonrecourse - 2026: $451; 2025: $438) | 10536 | 9183 |
| Long-Term Debt (variable interest entities nonrecourse - 2026: $184; 2025: $190) | 17254 | 17849 |
| Other Noncurrent Liabilities |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Deferred income tax liabilities | 348 | 364 |
| &nbsp;&nbsp;&nbsp;&nbsp;Pension and other postretirement benefits - noncurrent | 4542 | 4694 |
| &nbsp;&nbsp;&nbsp;&nbsp;Asbestos-related liabilities - noncurrent | 602 | 628 |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating lease liabilities - noncurrent | 1146 | 1097 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other noncurrent obligations | 8589 | 7201 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total other noncurrent liabilities (variable interest entities nonrecourse - 2026: $350; 2025: $364) | 15227 | 13984 |
| Stockholders' Equity |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Common stock (authorized 5,000,000,000 shares of $0.01 par value each;<br>issued 2026: 791,896,099 shares; 2025: 790,287,565 shares) | 8 | 8 |
| &nbsp;&nbsp;&nbsp;&nbsp;Additional paid-in capital | 11062 | 11112 |
| &nbsp;&nbsp;&nbsp;&nbsp;Retained earnings | 15992 | 16781 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accumulated other comprehensive loss | (7698) | (7660) |
| &nbsp;&nbsp;&nbsp;&nbsp;Treasury stock at cost (2026: 71,154,661 shares; 2025: 73,065,152 shares) | (4115) | (4233) |
| &nbsp;&nbsp;&nbsp;&nbsp;Dow Inc.'s stockholders' equity | 15249 | 16008 |
| &nbsp;&nbsp;&nbsp;&nbsp;Noncontrolling interests | 1514 | 1514 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total equity | 16763 | 17522 |
| Total Liabilities and Equity | $59780 | $58538 |

---

------

**Dow Inc. and Subsidiaries**

**Consolidated Statements of Cash Flows**

---

| | | |
|:---|:---|:---|
| In millions (Unaudited) | *Three Months Ended* | *Three Months Ended* |
| In millions (Unaudited) | *Mar 31,<br>2026* | *Mar 31,<br>2025* |
| Operating Activities |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net loss | $(445) | $(290) |
| &nbsp;&nbsp;&nbsp;&nbsp;Adjustments to reconcile net loss to net cash provided by operating activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | 719 | 714 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Credit for deferred income tax | (48) | (177) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Earnings of nonconsolidated affiliates less than dividends received | 502 | 133 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net periodic pension benefit credit | (8) | (26) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pension contributions | (41) | (31) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net gain on sales of assets, businesses and investments | (4) | (2) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Restructuring and asset related charges - net | 27 | 208 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other net (gain) loss | (14) | 185 |
| &nbsp;&nbsp;&nbsp;&nbsp;Changes in assets and liabilities, net of effects of acquired and divested companies: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts and notes receivable | (531) | (301) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Inventories | (180) | (221) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts payable | 551 | 38 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other assets and liabilities, net | 596 | (126) |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash provided by operating activities - continuing operations | 1124 | 104 |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash provided by (used for) operating activities - discontinued operations |  | (13) |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash provided by operating activities | 1124 | 91 |
| Investing Activities |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Capital expenditures | (503) | (685) |
| &nbsp;&nbsp;&nbsp;&nbsp;Proceeds from incentives related to capital expenditures | 40 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash flow hedging related to capital expenditures | 3 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Investment in gas field developments | (21) | (30) |
| &nbsp;&nbsp;&nbsp;&nbsp;Proceeds from sales of property, businesses and consolidated companies, net of cash divested | 4 | 3 |
| &nbsp;&nbsp;&nbsp;&nbsp;Investments in and loans to nonconsolidated affiliates |  | (3) |
| &nbsp;&nbsp;&nbsp;&nbsp;Purchases of investments | (331) | (104) |
| &nbsp;&nbsp;&nbsp;&nbsp;Proceeds from sales and maturities of investments | 319 | 416 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other investing activities, net | 41 | 2 |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash used for investing activities | (448) | (401) |
| Financing Activities |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Changes in short-term notes payable |  | (1) |
| &nbsp;&nbsp;&nbsp;&nbsp;Proceeds from issuance of short-term debt greater than three months | 4 | 11 |
| &nbsp;&nbsp;&nbsp;&nbsp;Payments on short-term debt greater than three months | (4) | (6) |
| &nbsp;&nbsp;&nbsp;&nbsp;Proceeds from issuance of long-term debt | 52 | 1013 |
| &nbsp;&nbsp;&nbsp;&nbsp;Payments on long-term debt | (46) | (957) |
| &nbsp;&nbsp;&nbsp;&nbsp;Collections on securitization programs, net of remittances |  | 15 |
| &nbsp;&nbsp;&nbsp;&nbsp;Transaction financing, debt issuance and other costs | (1) | (64) |
| &nbsp;&nbsp;&nbsp;&nbsp;Employee taxes paid for share-based payment arrangements | (14) | (16) |
| &nbsp;&nbsp;&nbsp;&nbsp;Distributions to noncontrolling interests | (59) | (22) |
| &nbsp;&nbsp;&nbsp;&nbsp;Dividends paid to stockholders | (252) | (494) |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash used for financing activities | (320) | (521) |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | (73) | 123 |
| Summary |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Increase (decrease) in cash, cash equivalents and restricted cash | 283 | (708) |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash, cash equivalents and restricted cash at beginning of period | 3952 | 2263 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cash, cash equivalents and restricted cash at end of period | $4235 | $1555 |
| &nbsp;&nbsp;&nbsp;&nbsp;Less: Restricted cash and cash equivalents, included in "Other current assets" | 125 | 90 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cash and cash equivalents at end of period | $4110 | $1465 |

---

------

**Dow Inc. and Subsidiaries**

**Net Sales by Segment and Geographic Region**

---

| | | |
|:---|:---|:---|
| **Net Sales by Segment** | *Three Months Ended* | *Three Months Ended* |
| In millions (Unaudited) | *Mar 31, 2026* | *Mar 31, 2025* |
| Packaging & Specialty Plastics | $4919 | $5310 |
| Industrial Intermediates & Infrastructure | 2626 | 2855 |
| Performance Materials & Coatings | 2080 | 2071 |
| Corporate | 169 | 195 |
| Total | $9794 | $10431 |
| U.S. & Canada | $3796 | $4227 |
| EMEAI <sup>1</sup> | 3184 | 3274 |
| Asia Pacific | 1738 | 1858 |
| Latin America | 1076 | 1072 |
| Total | $9794 | $10431 |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Net Sales Variance by Segment and Geographic Region** | *Three Months Ended Mar 31, 2026* | *Three Months Ended Mar 31, 2026* | *Three Months Ended Mar 31, 2026* | *Three Months Ended Mar 31, 2026* |
| **Net Sales Variance by Segment and Geographic Region** | *Local Price & Product Mix* | *Currency* | *Volume* | *Total* |
| Percent change from prior year | *Local Price & Product Mix* | *Currency* | *Volume* | *Total* |
| Packaging & Specialty Plastics | (9)% | 3% | (1)% | (7)% |
| Industrial Intermediates & Infrastructure | (8) | 4 | (4) | (8) |
| Performance Materials & Coatings | (4) | 2 | 2 |  |
| Total | (7)% | 3% | (2)% | (6)% |
| Total, excluding the Hydrocarbons & Energy business | (7)% | 3% | —% | (4)% |
| U.S. & Canada | (6)% | —% | (4)% | (10)% |
| EMEAI <sup>1</sup> | (9) | 8 | (2) | (3) |
| Asia Pacific | (8) | 2 |  | (6) |
| Latin America | (9) |  | 9 |  |
| Total | (7)% | 3% | (2)% | (6)% |

---

1. Europe, Middle East, Africa and India.

------

**Dow Inc. and Subsidiaries**

**Selected Financial Information and Non-GAAP Measures**

---

| | | |
|:---|:---|:---|
| **Operating EBIT by Segment** | *Three Months Ended* | *Three Months Ended* |
| In millions (Unaudited) | *Mar 31, 2026* | *Mar 31, 2025* |
| Packaging & Specialty Plastics | $208 | $342 |
| Industrial Intermediates & Infrastructure | (118) | (128) |
| Performance Materials & Coatings | 117 | 49 |
| Corporate | (53) | (33) |
| Total | $154 | $230 |
| **Depreciation and Amortization by Segment** | *Three Months Ended* | *Three Months Ended* |
| In millions (Unaudited) | *Mar 31, 2026* | *Mar 31, 2025* |
| Packaging & Specialty Plastics | $382 | $360 |
| Industrial Intermediates & Infrastructure | 148 | 146 |
| Performance Materials & Coatings | 181 | 200 |
| Corporate | 8 | 8 |
| Total | $719 | $714 |
| **Operating EBITDA by Segment** | *Three Months Ended* | *Three Months Ended* |
| In millions (Unaudited) | *Mar 31, 2026* | *Mar 31, 2025* |
| Packaging & Specialty Plastics | $590 | $702 |
| Industrial Intermediates & Infrastructure | 30 | 18 |
| Performance Materials & Coatings | 298 | 249 |
| Corporate | (45) | (25) |
| Total | $873 | $944 |
| **Equity in Losses of Nonconsolidated Affiliates by Segment** | *Three Months Ended* | *Three Months Ended* |
| In millions (Unaudited) | *Mar 31, 2026* | *Mar 31, 2025* |
| Packaging & Specialty Plastics <sup>1</sup> | $(63) | $39 |
| Industrial Intermediates & Infrastructure <sup>1</sup> | (242) | (58) |
| Performance Materials & Coatings | 1 |  |
| Corporate | 1 | (1) |
| Total | $(303) | $(20) |
| **Reconciliation of "Net loss" to "Operating EBIT"** | *Three Months Ended* | *Three Months Ended* |
| In millions (Unaudited) | *Mar 31, 2026* | *Mar 31, 2025* |
| Net loss | $(445) | $(290) |
| &nbsp;&nbsp;&nbsp;&nbsp;+ Provision (credit) for income taxes | 55 | (84) |
| Loss before income taxes | $(390) | $(374) |
| &nbsp;&nbsp;&nbsp;&nbsp;- Interest income | 42 | 28 |
| &nbsp;&nbsp;&nbsp;&nbsp;+ Interest expense and amortization of debt discount | 219 | 216 |
| &nbsp;&nbsp;&nbsp;&nbsp;- Significant items | (367) | (416) |
| Operating EBIT (non-GAAP) | $154 | $230 |

---

1. Packaging & Specialty Plastics and Industrial Intermediates & Infrastructure include losses of $81 million and $211 million, respectively, related to the Sadara guarantee liability adjustment, a significant item.

------

**Dow Inc. and Subsidiaries**

**Selected Financial Information and Non-GAAP Measures**

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Significant Items Impacting Results for the Three Months Ended Mar 31, 2026** | **Significant Items Impacting Results for the Three Months Ended Mar 31, 2026** | **Significant Items Impacting Results for the Three Months Ended Mar 31, 2026** | **Significant Items Impacting Results for the Three Months Ended Mar 31, 2026** | **Significant Items Impacting Results for the Three Months Ended Mar 31, 2026** |
| In millions, except per share amounts (Unaudited) | *Pretax* <sup>1</sup> | *Net income (loss)* <sup>2</sup> | *EPS* <sup>3</sup> | *Income Statement Classification* |
| Reported results | $(390) | $(533) | $(0.74) |  |
| Less: Significant items |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Transform to Outperform <sup>4</sup> | (80) | (63) | (0.09) | SG&A ($53 million); Restructuring and asset related charges - net ($27 million) |
| &nbsp;&nbsp;&nbsp;2025 Restructuring implementation costs <sup>5</sup> | (21) | (17) | (0.02) | &nbsp;&nbsp;Cost of sales ($20 million); <br>SG&A ($1 million) |
| &nbsp;&nbsp;&nbsp;Sadara guarantee liability adjustment <sup>6</sup> | (292) | (227) | (0.31) | Equity in losses of nonconsolidated affiliates |
| &nbsp;&nbsp;&nbsp;Litigation related charges, awards and adjustments <sup>7</sup> | 26 | 21 | 0.03 | Sundry income (expense) - net |
| &nbsp;&nbsp;&nbsp;Income tax related items <sup>8</sup> |  | (150) | (0.21) | Provision for income taxes |
| &nbsp;&nbsp;&nbsp;&nbsp;Total significant items | $(367) | $(436) | $(0.60) |  |
| Operating results (non-GAAP) | $(23) | $(97) | $(0.14) |  |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Significant Items Impacting Results for the Three Months Ended Mar 31, 2025** | **Significant Items Impacting Results for the Three Months Ended Mar 31, 2025** | **Significant Items Impacting Results for the Three Months Ended Mar 31, 2025** | **Significant Items Impacting Results for the Three Months Ended Mar 31, 2025** | **Significant Items Impacting Results for the Three Months Ended Mar 31, 2025** |
| In millions, except per share amounts (Unaudited) | *Pretax* <sup>1</sup> | *Net income (loss)* <sup>2</sup> | *EPS* <sup>3</sup> | *Income Statement Classification* |
| Reported results | $(374) | $(307) | $(0.44) |  |
| Less: Significant items |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Restructuring, implementation and efficiency costs, and asset related charges - net <sup>9</sup> | (51) | (39) | (0.05) | &nbsp;&nbsp;Cost of sales ($44 million); <br>R&D ($1 million); SG&A ($4 million); Restructuring and asset related charges - net ($1 million); Sundry income (expense) - net ($1 million) |
| &nbsp;&nbsp;&nbsp;2025 Restructuring Program <sup>10</sup> | (207) | (161) | (0.23) | &nbsp;&nbsp;Restructuring and asset related charges - net |
| &nbsp;&nbsp;&nbsp;Loss on early extinguishment of debt | (60) | (48) | (0.07) | Sundry income (expense) - net |
| &nbsp;&nbsp;&nbsp;Indemnification and other transaction related costs <sup>11</sup> | (98) | (76) | (0.11) | Cost of Sales |
| &nbsp;&nbsp;&nbsp;&nbsp;Total significant items | $(416) | $(324) | $(0.46) |  |
| Operating results (non-GAAP) | $42 | $17 | $0.02 |  |

---

1."Loss before income taxes."

2."Net loss available for Dow Inc. common stockholders." The income tax effect on significant items was calculated based upon the enacted tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment.

3."Losses per common share - diluted," which includes the impact of participating securities in accordance with the two-class method.

4. Costs to achieve and severance and related benefit costs associated with Transform to Outperform.

5. Implementation costs associated with the Company's 2025 Restructuring Program.

6. Loss due to change in fair value of the estimated liability associated with the Company's guarantee of Sadara's project financing debt.

7. Related to a gain associated with a legal matter with Nova Chemicals Corporation ("Nova").

8. Related to tax expense associated with the legal matter with Nova.

9. Restructuring charges and implementation and efficiency costs associated with the Company's 2023 Restructuring Program and impairment charges related to the write-down of certain manufacturing assets, partly offset by an asset related credit adjustment.

10. Severance and related benefit costs associated with the Company's 2025 Restructuring Program.

11. Includes a charge related to an arbitration settlement agreement for historical product claims from a divested business.

------

**Dow Inc. and Subsidiaries**

**Selected Financial Information and Non-GAAP Measures**

---

| | | |
|:---|:---|:---|
| **Reconciliation of Free Cash Flow** | *Three Months Ended* | *Three Months Ended* |
| In millions (Unaudited) | *Mar 31, 2026* | *Mar 31, 2025* |
| Cash provided by operating activities - continuing operations (GAAP) | $1124 | $104 |
| Capital expenditures | (503) | (685) |
| Free Cash Flow (non-GAAP) | $621 | $(581) |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Reconciliation of Cash Flow Conversion** | *Three Months Ended* | *Three Months Ended* | *Three Months Ended* | *Three Months Ended* |
| In millions (Unaudited) | *Jun 30, 2025* | *Sep 30, 2025* | *Dec 31, 2025* | *Mar 31, 2026* |
| Cash provided by (used for) operating activities - continuing operations (GAAP) | $(470) | $1130 | $298 | $1124 |
| Net income (loss) (GAAP) | $(801) | $124 | $(1477) | $(445) |
| Cash flow from operations to net income (GAAP) <sup>1</sup> | N/A | 911.3% | N/A | N/A |
| Cash flow from operations to net income - trailing twelve months (GAAP) <sup>2</sup> |  |  |  | N/A |
| Operating EBITDA (non-GAAP) | $703 | $868 | $741 | $873 |
| Cash Flow Conversion (Cash flow from operations to Operating EBITDA) (non-GAAP) | (66.9)% | 130.2% | 40.2% | 128.8% |
| Cash Flow Conversion - trailing twelve months (non-GAAP) |  |  |  | 65.4% |

---

1. Cash flow from operations to net income is not applicable for the second quarter and fourth quarter of 2025, and first quarter of 2026 due to a net loss for the period.

2. Cash flow from operations to net income - trailing twelve months is not applicable due to a net loss for the trailing twelve months period.

<br>